The monetary impact of zoonotic diseases on society: The Turkish Case

Abstract

In this study, the burden of disease, costs, and animal losses caused by the seven most common zoonoses in humans and the two most common zoonoses in animals are calculated between 2016-2018 in Turkey. It aims to contribute to the literature by providing a holistic framework on the costs and burden of diseases of zoonoses in Turkey. The methodology of the study was based on the formula of ''Disease Burden of Zoonotic Diseases'' developed by the FAO. It was calculated under ''Burden of Early Mortality in Humans'', ''Burden of Morbidity in Humans'', "Financial Value of Lost Animals" and "Reduction in Production Capacity of Infected Animals". All cases which were registered in 2016, 2017 and, 2018 from the Ministry of Health (MoH) and the Ministry of Agriculture and Forestry (MoAF) concerning the relevant diseases were included in the study. It is found that the DALYs of all related zoonotic diseases increased and the costs for diagnosis, treatment, and prevention also rose between 2016-2018. The share of total social cost in the GDP of Turkey was estimated to be 0.0090% in 2016, 0.0097% in 2017, and 0.0113% in 2018. It is argued that the seven zoonoses in the scope of this study have an increasing burden graph on Turkish society between 2016-2018. Moving from the fact that most infectious diseases that threaten human and community health are of zoonotic origin and difficulties in predicting when, where or how a zoonotic disease will occur, all sectors should continue to carefully monitor events related to zoonoses and carry out joint studies.

Keywords

• burden of diseases
• cost of zoonotic diseases
• Turkey
• zoonotic diseases

References

1. Al-Abri S, Abaidani SIA, Fazlalipour, et al (2017): Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. International Journal of Infectious Diseases, 58, 82–89.
2. Can, MF (2010): Türkiye’de Brusella Abortus ve Brusella Melitensis Enfeksiyonlarından Kaynaklanan Finansal Kayıplar ve Alternatif Brusella Kontrol Stratejilerinin Maliyet-Fayda Analizi. Doktora Tezi. Ankara Üniversitesi, Sağlık Bilimleri Enstitüsü, Ankara.
3. Dabanlıoğlu B (2005): Erzincan İli ve Yöresinde Brusella Seroprevalansı ve Seropozitif Olguların Klinik Bulgularla İlişkisi. Yüksek Lisans Tezi. Erciyes Üniversitesi, Sağlık Bilimleri Enstitüsü, Kayseri.
4. Falzon LC, Alumasa L, Amanya F, et al (2019): One Health in action: Operational aspects of an integrated surveillance system for zoonoses in western Kenya. Frontiers in Veterinary Science, 6, 252.
5. Food and Agriculture Organization of the United Nations (2018): The Monetary Impact of Zoonotic Diseases on Society: Egypt, Evidence from Two Zoonoses, 2018. Avaliable at http://www.fao.org/3/i9001en/I9001EN.pdf. (Accessed August 15, 2019).
6. Food and Agriculture Organization of the United Nations (2018): The Monetary Impact of Zoonotic Diseases On Society: Kenya, Evidence From Three Zoonoses, 2018. Avaliable at http://www.fao.org/3/i8968en/I8968EN.pdf. (Accessed August 15, 2019).
7. Franc KA, Krecek RC, Häsler BN, et al (2018): Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action. BMC Public Health, 18, 125.
8. Grace D, Gilbert J, Randolph T, et al (2012): The multiple burdens of zoonotic disease and an ecohealth approach to their assessment. Tropical Animal Health and Production, 44, 67-73.

9. Grace D, Mutua F, Ochungo P, et al (2012): Mapping of poverty and likely zoonoses hotspots. Zoonoses Project 4. Report to the UK Department for International Development. Nairobi, Kenya: ILRI.
10. Herrera-Araujo D, Mikecz O, Pica-Ciamarra U (2020): Placing a monetary value on the human health component of zoonotic diseases: A methodological note with an application to cysticercosis in Africa. Preventive Veterinary Medicine, 175, 104862.
11. IHME (2018): Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) DisabilityWeights. Institute for Health Metrics and Evaluation (IHME), Seattle, United States.
12. Karababa O (2020): Sağlığın Maliyeti. Avaliable at www.toraks.org.tr/ userfiles/file/Maliyet_A_Karababa.ppt. (Accessed March 31, 2020).
13. Kaufmann, AF, Meltzer MI, Schmid GP (1997): The Economic Impact of a Bioterrorist Attack are Prevention and Postattack Intervention Programs Justifiable? In: Emerging Infectıous Diseases. Editor: McDade JE. U.S. Department of Health and Human Services Publication, USA.
14. Kreindel SM, McGuill M, Meltzer M, et al (1998): The cost of rabies postexposure prophylaxis: one state's experience. Public Health Rep, 113, 247-251.
15. Lindahl JF, Vrentas CE, Deka RP, et al (2020): Brucellosis in India: Results of a collaborative workshop to define One Health priorities. Tropical Animal Health and Production, 52, 387-96.
16. Malhan S (2020): Zoonotik Hastalıkların Toplumsal ve Ekonomik Yükü: Brusella Örneği. Avaliable at https://docplayer.biz.tr/57659138-Zoono-k-hastaliklarin-toplumsal-veekonomik-yuku-brusella-ornegi.html. (Accessed March 31, 2020).
17. Ministry of Health (2019): Türkiye Zoonotik Hastalıklar Eylem Planı. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Yayın No: 1130, Ankara.
18. Molyneux D, Hallaj Z, Keusch GT, et al (2011): Zoonoses and marginalised infectious diseases of poverty: where do we stand? Parasites & Vectors, 4, 106.
19. Moradi G, Piroozi B, Alinia C, et al (2019): Incidence, mortality, and burden of crimean congo hemorrhagic fever and its geographical distribution in Iran during 2009-2015. Iranian Journal of Public Health, 48, 44-52.
20. Narra R, Maestri M, Budke CM, et al (2016): Costs Associated with Surgically Treated Cases of Abdominal Cystic Echinococcosis: A Single Center's Experience from 2008 to 2014, Pavia, Italy. Am J Trop Med Hyg, 95, 405-409.
21. Özgülbaş N (2014): Sağlık Sektöründe Hizmet ve Hastalık Maliyet Analizi. Siyasal Kitabevi, Ankara.
22. Piroozi B, Moradi G, Safari H, et al (2019): Incidence, mortality, and burden of human brucellosis and its geographical distribution in Iran during 2009-2015. Iranian Journal of Public Health, 48, 20-27.
23. Pisarski K (2019): The global burden of disease of zoonotic parasitic diseases: top 5 contenders for priority consideration. Tropical Medicine and Infectious Disease, 4, 44.
24. Singh BB, Khatkar MS. Aulakh RS, et al (2018): Estimation of the health and economic burden of human brucellosis in India. Preventative Veterinary Medicine, 154, 148-155.
25. Schurer JM, Rafferty E, Schwandt M, et al (2016): Toxoplasmosis and Toxocariasis: An Assessment of Human Immunodeficiency Virus Comorbidity and Health-Care Costs in Canada. Am J Trop Med Hyg, 95, 168–174.
26. Torgerson PR, Rüegg S, Devleesschauwer B, et al (2018): zDALY: an adjusted indicator to estimate the burden of zoonotic diseases. One Health, 5, 40-45.
27. World Health Organization (2018): WHO Methods and Data Sources for Global Burden of Disease Estimates 2000-2016. Department of Information, Evidence and Research.
28. World Health Organization (2019): Neglected Tropical Diseases. WHO website. Avaliable at https://www.who.int/neglected_diseases/zoonoses/infections_more/en. (Accessed August 15, 2019).
29. Yıldırım C, Afşar Z, Eker L (1996): Brusellaun Dünyadaki Durumu ve Türkiye’de Brusella Epidemiyolojisi. Sağlık Bakanlığı Yayınları. Ankara 1996. s:568-570.
30. Zacchia NA and Schmitt K (2019): Medical Spending for the 2001 Anthrax Letter Attacks. Disaster Med Public Health Preparedness, 13, 539-546.
31. Zinsstag J, Schelling E, Roth F, et al (2007): Human benefits of animal interventions for zoonosis control. Emerging Infectious Diseases, 13, 527.